Zydus receives final approval from USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety
Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).
Integration of modern and traditional medicine to facilitate the illness to wellness journey
Essex enriches and complements Emmes’ services
Women of all ages will get round-the-clock access to comprehensive treatment
FedEx will be displaying a wide-range of effective healthcare packaging and specialized tracking technology
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
Subscribe To Our Newsletter & Stay Updated